The U.S. Preventive Services Task Force does not recommend prostate-specific antigen (PSA)-based screening of men of any age, assigning a grade D recommendation ("moderate to high certainty of no net benefit, or the harms outweigh the benefits"). However, this recommendation does not apply to use of PSA testing as a surveilllance method of men already diagnosed with prostate cancer, or to monitor treatment.
Study mentioned: Moyer VA. Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement. 2012 Jul 17; 157(2): 120-134. PMID 22801674
No comments:
Post a Comment